Latest Breaking News On - Algernon pharmaceuticals inc - Page 5 : comparemela.com

Short Interest in Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Grows By 33.3%

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More - ATAI Life Sciences (NASDAQ:ATAI), Algernon Pharmaceuticals (OTC:AGNPF)

First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More

First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published The American Psychedelic Practitioners Association (APPA) .

Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke Study

VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), has completed a feasibility study and has finalized its clinical trial design for a 40 patient Phase 2 DMT Stroke study. AGN Neuro is the world’s first company to investigate DMT for the tre

Natural Immune Booster Market to Reach $19.67 Billion by

Discover the power of natural immune boosters! Embrace the benefits of ginger, gooseberries (amla), and turmeric, which are among the remarkable superfoods.